Tagged with HE

Ministry of Health (MOH) of Malaysia Would you begin by giving our readers a brief overview of the recent changes in the Ministry of Health’s focus? After Prime Minister Najib changed Malaysia’s economic policy from the ‘New Economic Policy’ to the ‘Economic Transformation Programme’ there has been a paradigm shift in the ministry’s focus. The government…

Chemical Company Malaysia (CCM) Would you start off by giving our readers some of CCM’s background? CCM started in Malaysia as part of the ICI group of companies in 1930. In the 1960s ICI localised and sold off a percentage of its shares to Permodalan Nasional Berhad (PNB). In 1995 there was a management…

Taiwan Department of Health Paul Krugman, who won the 2006 Nobel Prize in economics, said that the Taiwanese health care system is the best in the world. Despite this, you are now drafting a second generation of legislation, so what are the issues that need to be addressed in this legislation? In any program…

Department of Health (DOH) Universal Health Care for All Filipinos: Making this dream a Reality I assumed office as your secretary of health barely a month ago with this single order from the president: make the dream of universal healthcare for all Filipinos a reality. This shall be the standard by which my performance,…

Department of Health (DOH) The new Government took office on the 1st of July, but we would like to hear about your experience as Secretary of Health. You took office at a particular time (January 2010) when the industry was still dealing with the first round of the MDRP price reductions and while you…

Philippines In an exclusive interview, Benjamin Liuson, president of The Generics Pharmacy in the Philippines on the company’s illustrious history, remarkable growth, and increasing acceptance of generics more generally in the Philippines. The Generics Pharmacy originated from a family business and you are the visionary who transformed it into what it…

Novartis Healthcare Philippines We have interviewed Novartis in several emerging markets including Colombia, Turkey, South Korea and Thailand. As the South East Asia Cluster Head, what is the importance of the South East Asia region for Novartis and what role do you feel the emerging markets play for the company? More companies are…

IMS Health Philippines You worked as a Country Manager in Indonesia and Thailand prior to joining IMS Health in the Philippines. What, in your opinion, sets this market apart? For starters, Indonesia is dominated by domestic players that, together, constitute 70% of the market. In the Philippines we see quite the opposite— a…

Philippine Chamber of the Pharmaceutical Indu The Philippine Chamber of Pharmaceutical Industries was established in 2004 from the merger of four different associations (Chamber of Filipino Drug Manufacturers and Distributors, Association of Drug Industries of the Philippines, Filipino Drug Association, and Association of Philippine Pharmaceutical Manufacturers). Can you tell to our readers what the rationale behind…

Array You have been active in the Philippines pharmaceutical sector for more than 30 years. Can you please tell to our readers how this sector has evolved, what the current situation of the pharmaceutical industry is? Furthermore, what is its importance for the local economy? There have been great changes in…

Chungcheongbuk-do Although Chungcheongbuk-do is a small province in terms of territory and population, it has gained increasing importance in Korea’s economy. What are the main drivers of this growing economic progression? Chungbcheongbuk-do (Chungbuk) was traditionally an agriculture-based province until its economy started to shift towards more knowledge intensive activities in the…

Minister of Higher Education and Research What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart of the research strategy in France? French research produces excellent results, but still suffers from a lack of international visibility,…